Quality of life of psoriatic patients – modulatory variables

Background. In recent years, there has been increasing interest in the quality of life (QoL) of patients with dermatological conditions. The problem of the stigma associated with some dermatological conditions has been discerned, as patients suffering from chronic dermatoses tend to perceive thems...

Full description

Bibliographic Details
Main Authors: Marta Maria Gawlik, Barbara Topczewska, Donata Kurpas
Format: Article
Language:English
Published: Continuo 2016-09-01
Series:Family Medicine & Primary Care Review
Subjects:
Online Access:https://www.termedia.pl/Quality-of-life-of-psoriatic-patients-modulatory-variables,95,28430,1,1.html
id doaj-cd7dc09eddd64c448d51ab522dfa1754
record_format Article
spelling doaj-cd7dc09eddd64c448d51ab522dfa17542020-11-24T22:27:15ZengContinuoFamily Medicine & Primary Care Review1734-34022449-85802016-09-0118323524010.5114/fmpcr/6255928430Quality of life of psoriatic patients – modulatory variablesMarta Maria GawlikBarbara TopczewskaDonata KurpasBackground. In recent years, there has been increasing interest in the quality of life (QoL) of patients with dermatological conditions. The problem of the stigma associated with some dermatological conditions has been discerned, as patients suffering from chronic dermatoses tend to perceive themselves in a specific way and to assess their QoL as very low. Objectives. Identification of factors that influence the QoL of patients with psoriasis. Material and methods . This survey-based quantitative research was carried out at the dermatology ward of the Voivodeship Specialist Hospital, Research and Development Centre in Wroclaw, Poland. The study involved 130 adult patients with a diagnosis of psoriasis, of whom 56.92% (74) were women. The research instruments used were the Dermatology Life Quality Index (DLQI), the Hospital Anxiety and Depression Scale (HADS), and a questionnaire of the authors’ own design. Results . The median for disappearance of psoriatic patches after hospitalization was 5 (range: 0–10). The median for the remission duration was 3 months (range: 0.25 to 24). 61.54% (80) of those surveyed reported improvement in their psoriasis treatment as a result of regular check-ups at the outpatient dermatology clinic. Disease-related anxiety and QoL were determined by marital status and the level of education. Older patients more often had symptoms of depression, according to HADS. Higher DLQI scores correlated with higher HADS-A and HADS-D scores. Conclusions . Psoriasis has significant effects on patients’ mental states and social functioning. The most serious and unpleasant symptoms are pruritus and skin lesions on the uncovered parts of the body. The patients with the highest risk of a lower QoL are the elderly; those living alone (single or widowed); those with secondary, vocational, or no education; and those with symptoms of anxiety or depression.https://www.termedia.pl/Quality-of-life-of-psoriatic-patients-modulatory-variables,95,28430,1,1.htmlpsoriasis anxiety quality of life
collection DOAJ
language English
format Article
sources DOAJ
author Marta Maria Gawlik
Barbara Topczewska
Donata Kurpas
spellingShingle Marta Maria Gawlik
Barbara Topczewska
Donata Kurpas
Quality of life of psoriatic patients – modulatory variables
Family Medicine & Primary Care Review
psoriasis
anxiety
quality of life
author_facet Marta Maria Gawlik
Barbara Topczewska
Donata Kurpas
author_sort Marta Maria Gawlik
title Quality of life of psoriatic patients – modulatory variables
title_short Quality of life of psoriatic patients – modulatory variables
title_full Quality of life of psoriatic patients – modulatory variables
title_fullStr Quality of life of psoriatic patients – modulatory variables
title_full_unstemmed Quality of life of psoriatic patients – modulatory variables
title_sort quality of life of psoriatic patients – modulatory variables
publisher Continuo
series Family Medicine & Primary Care Review
issn 1734-3402
2449-8580
publishDate 2016-09-01
description Background. In recent years, there has been increasing interest in the quality of life (QoL) of patients with dermatological conditions. The problem of the stigma associated with some dermatological conditions has been discerned, as patients suffering from chronic dermatoses tend to perceive themselves in a specific way and to assess their QoL as very low. Objectives. Identification of factors that influence the QoL of patients with psoriasis. Material and methods . This survey-based quantitative research was carried out at the dermatology ward of the Voivodeship Specialist Hospital, Research and Development Centre in Wroclaw, Poland. The study involved 130 adult patients with a diagnosis of psoriasis, of whom 56.92% (74) were women. The research instruments used were the Dermatology Life Quality Index (DLQI), the Hospital Anxiety and Depression Scale (HADS), and a questionnaire of the authors’ own design. Results . The median for disappearance of psoriatic patches after hospitalization was 5 (range: 0–10). The median for the remission duration was 3 months (range: 0.25 to 24). 61.54% (80) of those surveyed reported improvement in their psoriasis treatment as a result of regular check-ups at the outpatient dermatology clinic. Disease-related anxiety and QoL were determined by marital status and the level of education. Older patients more often had symptoms of depression, according to HADS. Higher DLQI scores correlated with higher HADS-A and HADS-D scores. Conclusions . Psoriasis has significant effects on patients’ mental states and social functioning. The most serious and unpleasant symptoms are pruritus and skin lesions on the uncovered parts of the body. The patients with the highest risk of a lower QoL are the elderly; those living alone (single or widowed); those with secondary, vocational, or no education; and those with symptoms of anxiety or depression.
topic psoriasis
anxiety
quality of life
url https://www.termedia.pl/Quality-of-life-of-psoriatic-patients-modulatory-variables,95,28430,1,1.html
work_keys_str_mv AT martamariagawlik qualityoflifeofpsoriaticpatientsmodulatoryvariables
AT barbaratopczewska qualityoflifeofpsoriaticpatientsmodulatoryvariables
AT donatakurpas qualityoflifeofpsoriaticpatientsmodulatoryvariables
_version_ 1725750673971085312